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INTRODUCTION 
This world is filled with beautiful 
things. We have only to look beneath 
the surface of the commonplace. 
Forty yeaors ago, adipose tissue was believed to be connective 
tissue which was relatively inactive metabolically. Today we know 
this tissue is highly active and an importsoit part of energy metab­
olism (Wertheimer, 1965). Mainy drugs aoid hormones are known to 
influence adipose tissue metabolism. Among these are the thyroid 
hormones which enhance lipolysis by increasing the sensitivity of 
adipose tissue to the catecholamines (Debons and Schwartz, 1961; 
Bray aind Goodman, 1965; Steinberg and Vaughain, 1965; Goodman and 
Bray, 1966; Fain, 1973). The effects of testosterone and estrogen 
upon the activity of the thyroid gland axe not cleaar. Because of 
the importance of thyroid hormones in lipolysis, the first part of 
this study was directed to examine the effects of testosterone and 
estrogen on the rate of secretion of thyroxine from the rat thyroid 
gland. 
In recent years, numerous studies have been published indicat­
ing that adipose cell size and number affect lipid metabolism. 
Adipose cell size and number have been reported to be influenced 
by age (Hirsch aind Han, 1969) , nutrition (Knittle and Hirsch, 1968), 
exercise (Oscai et al., 1972), cold exposure (Therriault et aJL., 
1969) and human growth hormone (Knittle ^  , 1971) . In view of 
these findings, the purpose of the second portion of this study was 
2 
to determine the effects of testosterone aoid estrogen on cell size 
and number in the retroperitoneal fat depot of male rats. 
Lipolysis is stimulated by the following hormones: adreno-
corticotrophic hormone, thyroid stimulating hormone, epinephrine, 
norepinephrine, glucocorticoids, glucagon, and thyroid hormones 
(Shafrir and Wertheimer, 1965; Goodman, 1970; Fain, 1973). Testos­
terone sind estrogen affect serum lipoprotein, phospholipid, tri­
glyceride and cholesterol levels (Furman et , 1967; Furman, 1969; 
Alfin-Slater and Aftergood, 1971; Solyom, 1972). However, literature 
dealing with the effects of these hormones on the lipid mobilizing 
ability of adipose tissue is scanty. The final portion of this 
study was designed to determine the effects of testosterone and 
estrogen on serum free fatty acids and on free fatty acid mobiliza­
tion from rat retroperitoneal fat depots. 
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REVIEW OF LITERATURE 
Effects of Sex Hormones on Thyroid Activity 
Evidence of a relationship between the thyroid gland and the 
gonads has been suggested by the observations that thyroid disorders 
are more frequent during puberty, pregnancy, and menopause (Ingbar 
aoid Woeber, 1968). Thyroid disorders have been reported to disrupt 
the normal menstrual cycle in females emd cause impôtency or loss 
of libido in males (Guyton, 1966). Based upon these observations, 
animal studies have been undertaken to determine the effects of sex 
hormones on thyroid function. Many of these studies aire contradic­
tory, possibly due in part to the variety of experimental conditions 
used. 
Androgens 
Intact male rats injected with 5.0 mg testosterone propionate 
(TP) daily for ten days exhibited increased uptake of by the 
thyroid gland, indicating increased thyroid activity (Money et , 
1950). In a second study. Money et (1951) used the same experi­
mental conditions, but substituted testosterone for TP. The rate 
131 
of I uptake in these animals was unchanged from control values. 
Kochakiaoi and Evans (1956) found no change in thyroidal uptake 
131 
or release of I in castrated rats or in castrated rats receiving 
1.0 mg TP daily for 10, 20, or 39 days. Jonkers et (1957) also 
131 found the uptake of I unchanged in gonadectomized male and female 
rats receiving 1.0 mg TP daily for seven days. In contrast, a 
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significant decrease in I uptake was observed in gonadectomized 
male and femaile rats given 2.0 mg TP daily for eight days and in 
ovariectomized females given 2.0 mg TP daily for 30 days (Lampe 
and Noach, 1962). These investigators also obtained evidence that 
131 
TP increases the urinairy excretion of I. 
Thyroid function has also been examined indirectly by deter­
mination of pituitary and serum levels of thyroid stimulating 
hormone (TSH). Van Rees ^  (1965) and D'Angelo (1966) reported 
a significant decrease in both pituitary amd serum concentrations 
of TSH after gonadectomy in matle and female rats. Treatment of 
castrated males with a low dosage of TP (100 (jg per day) caused an 
increase in the pituitary level of TSH, while a higher dosage (2.0 
mg per day) caused a decrease in pituitary TSH. Both dosages caused 
an increase in serum TSH values. These changes were evident in 
animals treated for 14 and 28 days, but were not observed in animals 
treated for seven days. Castrated, thyroidectcnizsd rats treated 
with TP and thyroxine (T^) exhibited an increase in serum levels 
3Jid a decrease in pituitary levels of TSH, When the T^ treatment 
was omitted, TP treatment had no effect on either serum or pituitary 
TSH levels (Vsm Rees et , 1965) . 
Gregerman and Crowder (1963) examined the T^ fractional turnover 
rate in normal males and females from two strains: Osborne-Mendel 
(2-3 months old) and Wistar (12 months old). The T^ fractional turn­
over rate was greater in females than in males of both strains. 
While a strain difference was observed in plasma T^ concentrations. 
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higher levels were found in male Osborne-Mendel and in female Wistar 
rats. 
Utilizing the iodine-131-thyroxine substitution method, 
Kumaresan and Turner (1967b) found no differences in the thyroid 
secretion rates (TSR) of normal male and female rats of similar age. 
In another study, intact female rats were injected at 36-48 hours 
postnatally with a single 2.0 mg dose of TP. The TSR was measured 
118 days later. The TP-treated animals exhibited a 16 percent de­
crease in TSR as compared with control animals (Kumaresan and Turner, 
1966). A third study by Kumaresan and Turner (1967a) showed that 
castration of rats resulted in a 12 percent reduction in the TSR, 
while replacement therapy with 2.0 mg TP per day resulted in a 21 
percent increase over control values and a 35 percent increase over 
the castrated animal TSR. When intact males were given the same 
dosage of TP, the TSR increased 25 percent over the control TSR 
values. 
Estrogens 
Paschkis and co-workers (1948) found no differences in thyroid 
131 function when they examined I uptaJce in control, ovaoriectomized, 
and estradiol benzoate (EB) treated rats. Administration of 
131 
estrone to maJLe rats was found to increase I uptake and decrease 
131 
I release (Florsheim, 1958). Ovariectomy of rabbits had no 
131 
effect on I uptake and release. In rats, no correlation was 
131 found between the stage of the estrous cycle and I release 
(Brown-Grant, 1956). 
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Wolterink et (1950) observed that the response of the 
thyroid varied with the dosage of the hormone used. Iodine-131 
turnover in the thyroid was increased with low doses of stilbesterol 
(1.0 lag) and decreased with high doses (10 p,g and 100 |j,g) in mice 
and rats. Reineke and Solimam (1953) and Soliman and Reineke (1955) 
131 
reported am increase in I uptake when ovariectomized rats were 
131 
treated with 1.0 p,g EB and no effect on I uptake with higher 
doses. 
In contrast, Noach (1955) found an increase in the uptake of 
"^"^•^I in intact and castrated rats receiving EB in doses ranging 
from 10 to 1000 jj.g daily. Reports by Feldman (1956) indicate that 
131 I uptake was increased during estrus in the rat. Iodine-131 up­
take was also increased when estrogen was given for short periods 
of time to intact males and females and to castrated rats. The ob­
served response was dependent on dosage, with higher doses increas­
ing uptake more than lower doses. Injections of estrogen for a 
131 prolonged period of time would either prevent or depress I 
uptake. 
When EB (2-5 |j,g daily) was administered for two days to intact 
and ovariectomized rats, a significant increase was observed in 
127 X31 
thyroid uptaike of I and I (Galton, 1971). An increased rate 
^ 131^ ^ . 131^ 
of I excretion in urine and a decrease in serum I-thyroxine 
levels were also observed in EB treated animals. The author sug­
gested this indicated an increase in the rate of T^ deiodination. 
These chamges were most appairent after two days of treatment and 
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disappeared after 10 days of treatment. 
Boccabella and Alger (1964) examined the thyroid : serum 
radioiodide concentration ratios in gonadectomized male amd 
female rats treated with EB. In both sexes, there was an increase 
in the concentration ratio which was not dependent on dosage (1-250 
(ag). However, there was a difference in the response with time. 
The concentration ratio increased immediately in the castrated 
males, while in the ovauriectomized females there was first a de­
crease cLnd then an increase. 
Reports in the literature aare conflicting as to whether the 
pituitary must be present in order for estrogens to affect a change 
in thyroid activity. Clifton and Meyer (1956) observed thyroid 
hypertrophy and suggested that diethylstilbesterol caused an in­
crease in TSH secretion from the rat pituitary. An increase in 
131 I uptake in hypophysectomized female rats treated with EB was 
observed by Feldnan (1956) and Galton (1971). The thyroid : scrur: 
radioiodide concentration ratio was also increased in hypophysecto­
mized rats treated with EB (Boccabella and Alger, 1964). In con-
131 trast, EB treatment had no effect on I uptake in hypophysectomized 
rats (Noach, 1955) or in ovariectomized, hypophysectomized rats 
(Soliman and Reineke, 1955). 
A 33 percent decrease in the TSR was observed in ovariectomized 
rats. Replacement therapy with 1.0 |jg EB per day restored the TSR 
to the level of normaJL controls (Moon and Turner, 1960). Grosvenor 
and Turner (1959) examined the effects of various dosages of EB on 
8 
the TSR. Intact female rats were injected for five days with 
either 1.0, 3.6, 15, or 50 |ig EB per day. The TSR increased 35.5 
percent in animals treated with 3.6 jjg EB as compared to control 
animal TSR. The other dosages were without effect. 
Administration of 1.5 |j,g EB for four weeks to ovaoriectomized 
rats resulted in an increase in the TSR over the values observed 
in untreated ovariectomized ainimals (Grosvenor, 1962). When TSH 
secretion was totally suppressed by exogenous T^, EB did not cause 
131 131 
I release from the thyroid. There was a mairked increase in I 
release from the thyroid when TSH secretion was partially suppressed. 
The author suggested this indicated that EB does not act directly 
upon the thyroid. In a second experiment, Grosvenor found EB in-
131 
creased urinary and fecal excretion of I after a single injection 
131 
of I-thyroxine. This suggested that EB increased the rate of 
T^ degradation. 
Adipose Tissue Cellularity 
Factors affecting cellulaxity 
The size of a fat depot has been shown to be dependent upon 
two factors, the number of fat cells or adipocytes and the size of 
the adipocyte. Hirsch and Hsm (1969) studied the size, number, and 
formation of mature adipocytes in epididymal and retroperitoneal 
adipose tissue of the rat. Early development of these tissues 
was accomplished by increases in cell number and in cell size, up 
to 15 weeks of age. Beyond this age, fat depots grew by increase 
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in cell size alone. Studies by Haartman ^  (1971) supported 
these findings. However, Hubbard and Matthew (1971), also study­
ing rat epididymal fat cells, found that hyperplasia ceased by nine 
weeks of age and hypertrophy accounted for all epididymal fat pad 
growth after that age. Hirsch and Han (1969) suggested that as 
adipose tissue ages it loses the ability to grow by hyperplasia 
of the fat cells amd grows only by hypertrophy. Thus, adipose 
tissue is intermediate between neurons which do not undergo mitosis 
after eaxly life, and liver cells which axe capable of mitosis 
throughout life. 
Supporting evidence for the observed increase in adipocyte 
cell number with age has been reported by many laboratories. Ho11en-
berg and Vost (1968) have found evidence for the existence of pre­
cursors of the adipocyte in young rats. While DiGirolamo and 
Mendlinger (1971) observed an increase in epididymal fat cell num­
ber in older rats, hamsters, and guinea pigs when compcured with cell 
numbers of young ainimals. In addition, studies of obese and non-
obese humans have shovjn obese individuals to have larger and often 
more numerous fat cells than nonobese individuals (Bray, 1970; 
Hirsch and Knittle, 1970). Individuals who became obese at an eaxly 
age were found to have higher fat cell numbers than individuals who 
became obese later in life. This led Hirsch and Knittle to suggest 
that the age of onset of obesity was related to the increase in cell 
number. 
The time in life when adipocytes stop proliferating has been 
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reported to vary with the location of the fat depot, and the strain 
and species of the animal. Studies with the nonobese Zucker rat 
have indicated that cell numbers increase until the fourteenth week 
of age. At this time, the cell number became fixed in the epididymal 
and retroperitoneal fat depots. The number of cells contijiued to 
increase in the subcutaneous depot until 26 weeks of age. Increases 
in the cell number of all three fat depots were observed in the 
obese Zucker rat up to 26 weeks of age (Johnson ^  , 1971) . 
Adipocyte number became fixed before weaning in the lean Swiss 
albino (NCS/R) mouse and in the obese strains, yellow (aA^) and 
viable yellow (aA^^) mice (Johnson and Hirsch, 1972). 
Control of nutritional levels eairly in life has been shown to 
permanently change the size of the rat epididymal fat pad and also 
the size and number of cells in that depot (Knittle and Hirsch, 
1968). Animals deprived of adequate nutrition from birth to weein-
ing and given free access to food after weaning had significaoitly 
smaller fat cell numbers and fat cell size, by 20 weeks of age, 
than did animals receiving adequate nourishment. Starvation 
of animals during the sixth and fifteenth week of life had no 
effect on cell number, but did decrease cell size. Re-feeding 
restored cell size to that observed in control animals (Hirsch and 
Han, 1969). Similar results were obtained in a study of young rat 
epididymal fat pads by Goldrick (1967). This study also indicated 
an increase in lipid and cytoplasmic components of the cell may 
occur during cell enlargement. 
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Hubbard and Matthew (1971) found no change in fat cell number 
in the epididymal fat pads of young rats subjected to chronic 
underfeeding, but did find a decrease in total fat pad DNA.. These 
authors suggested that the ratio of fat cells to nonfat cells in the 
fat pad may be altered by starvation. 
DiGirolamo and co-workers (1973) studied the effects of dif­
ferent types of diets on the cellularity of epididymal and perirenal 
fat depots of rats maintained on the diets from five weeks of age 
until the age of 13 weeks. No change in fat cell number was ob­
served in rats fed high carbohydrate, high protein, nor high fat 
diets. However, the animals maintained on the high fat diet did 
have more body fat and larger cells than the aoiimals maintained on 
the other two diets. 
Restriction of food intake from birth to 15 weeks of age re­
sulted in a reduction in cell number and cell size in rat epididymal 
fat pads. Epididymal fat cell nuzbsr and size v;srs decreased even 
more in chronically exercised rats. These animals, given free 
access to food, were exercised by swimming from eight days of age 
to 14-16 weeks of age (Oscai ^ t al., 1972). 
Exposure of young rats to cold temperatures (5°C) has been 
shown to alter epididymal fat cell number and size (Therriault 
et al., 1969; Therriault and Mellin, 1971). As long as the animals 
were maintained in the cold, fat cell numbers increased throughout 
life, while the size of the cells remained small. When the animals 
were removed from the cold and placed at ambient temperature (25°C), 
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hyperplasia ceased aoid hypertrophy was initiated. The fat pads of 
older animals, raised at 25°C and then maintained in the cold, grew 
only by hypertrophy. 
Knittle et al. (1971) reported that administration of human 
growth hormone caused an increase in adipose cell number aind size 
in two patients with growth hormone deficiency (ages, six and eight 
years) and one patient with thyroid stimulating hormone deficiency 
(age, 4 yeaors). Although the hormone chemged fat cell number and 
size, it did not appear to be required for early celluleir develop­
ment. 
Fat cell numbers have been shown to be unaffected by the 
destruction of the ventromedial hypothalamic nuclei. Hypertrophy 
of the cells was responsible for the obesity which followed this 
treatment (Hirsch and Han, 1969; Johnson ^  , 1971; Johnson and 
Hirsch, 1972). 
Insulin administration to male rats beginning at birth, one, 
three, or 10 weeks of age did not cause an increase in adipose cell 
number in the epididymal, retroperitoneal, or subcutaneous fat depots 
(Salams ^  , 1972). In all treatment groups, there was an en­
largement of fat cells resulting in laorger fat depots ajid an in­
creased rate of weight gain. Approximately 15 percent of the in­
creased weight of the fat depots was due to an increase in nonlipid 
material. The authors suggested that this was due to insulin stimu­
lated protein synthesis in adipocytes and connective tissue. 
Studies have not been published examining the effects of the 
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sex hormones on adipose cell size and number. However, sexual dif­
ferences in adipose tissue have been reported in mice by Johnson and 
Hirsch (1972), Male mice were observed to weigh the same or slightly 
more than female mice, even though the females were fatter. In the 
strains of mice studied, the weights of gonadal, retroperitoneal and 
subcutaneous fat depots were greater in females than in males. Cell 
size in the enlarged fat depots of the females varied with strains. 
Swiss albino and C57BL/6J female mice had Isirger cells in the sub­
cutaneous fat depot than the males, while cell sizes in the gonadal 
and retroperitoneal fat depots were the same in both sexes. Females 
of the strains intermediate yellow (aiA^^) and yellow (aA^) had 
larger fat cells in all three depots. No sex differences in cell 
size were observed in New Zealand and diabetic (dbdb) mice. In 
the obese-hyperglycemic (obob) strain, females were heavier and 
fatter than male mice. The males had larger fat cells, but the 
females had twice as many cells in the gonadal fat pad and three 
times more in the subcutaneous fat depot. 
Effects of adipose tissue cellularitv on lipid mobilization 
Zucker (1972) observed differences in the rate of free fatty 
acid (FFA) release from different adipose tissue sites in the obese 
and nonobese Zucker rat. The epididymal fat pad had the highest 
rate of FFA release, followed by the retroperitoneal and sub­
cutaneous fat depots. The obese rats had a higher FFA release 
tham the nonobese rats. When the obese and nonobese rats were sub­
jected to fasting, the obese animals started out with higher plasma 
14 
FFA levels than the nonobese animal. By the sixth day of fasting, 
the FFA levels of both groups were similar, although the obese 
emimals exhibited and maintained a higher plasma glycerol level. 
After eight days, the FFA levels began to decrease in the nonobese 
ajiimals as their fat stores were depleted. The obese animals main­
tained the high, stable FFA level for 70 days. 
In a study of the effects of glucose aoid insulin on the rate 
of lipolysis in human subcutaneous adipose tissue. Smith (1970) 
found a decrease in glycerol release when the medium lacked glucose, 
but contained insulin. When glucose was added, the rate of lipolysis 
increased. Adipose cell size had no effect on the rate of lipolysis 
when glucose was absent from the medium. However, in the presence 
of glucose, lipolysis was increased in the larger fat cells. While 
studies by Jacobsson and Smith (1972) indicated that lairge human 
adipocytes appesared to be as sensitive to the auitilipolytic action 
of insulin as small adipocytes. 
Human subcutaneous fat cells (large adipocytes) were found to 
have a higher basal rate of glycerol release than omental fat cells 
(small adipocytes). This difference was also observed when lipolysis 
was stimulated with theophylline, but not when epinephrine was added. 
Thus, the subcutaneous fat cells were not as sensitive to the effects 
of epinephrine as the omental fat cells. Cell volume was responsible 
for the different rates of lipolysis observed in subcutaneous and 
omental fat cells (Goldrick and McLoughlin, 1970). The basal rate 
of glycerol release and the release stimulated by salbutamol, 
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noradrenaline, adrenaline, and isopropylnoradrenaline increased as 
human subcutaneous fat cell size increased. These increases were 
more closely correlated with cell surface sorea than with cell diam­
eter or volume (Jacobsson and Smith, 1972). 
Zinder and Shapiro (1971), using rat epididymal fat pads, found 
FFA release to be dependent on cell surface area. When epinephrine 
was present in the incubation medium, the rate of lipolysis per 
cell increased as cells became larger. The authors observed no FFA 
release in the absence of epinephrine. Research by Cushman and Salsins 
(1973) supported these findings and added the observation that lairger 
fat cells release more fatty acids per unit of glycerol than smaller 
cells. 
Free fatty acid release per cell from epididymal fat pads of 
nonobese and obese Zucker rats was higher in the obese animals at 
the age of 13 weeks, when incubated in the absence or presence of 
lov; levels of epinephrine (Zucker, 1972). At 25 weeks of age, there 
was no difference in FFA release per cell. However, because the older 
obese animals had a greater number of cells, the capacity for lipid 
mobilization was greater thsin in the nonobese rats. The levels of 
FFA released were the same from tissues of obese and nonobese 
animals when lipolysis was stimulated by high levels of epinephrine, 
Zucker (1972) also examjLoed the effects of age of obese and 
nonobese Zucker rats on plasma FFA sind glycerol levels. At two 
weeks of age, there was no difference between the two groups. The 
glycerol level became elevated in the obese rat at four weeks of 
16 
age, and the FFA level rose at five to six weeks of age. These 
levels continued to increase until the age of 25 weeks. Female 
obese rats exhibited a higher increase than male rats. The FFA 
2uid glycerol levels in the nonobese rat remained stable with no 
indication of sex differences. When epinephrine was given to 15 
week old amimals vivo, plasma FFA and glycerol levels rose more 
in the obese than in the nonobese amimaJL. The ratio of FFA to 
glycerol was three for the treated and untreated nonobese and 
treated obese animaJLs. The value was 1.4 in the untreated obese 
animal, which indicated a recycling of fatty acids back into adipose 
tissue triglycerides. Liver fat and muscle FFA levels rose in the 
obese and nonobese animals after epinephrine treatment. However, 
the levels were higher in the obese amimals. 
Hartman and co-workers (1971) found the basal release of glycerol 
per cell, from rat epididymal fat cells, increased as cell size 
increased. When the rate of lipolysis was expressed in terms of cell 
surface area, an inverse relationship existed between lipolysis and 
cell size. Lipolysis and adenyl cyclase activity stimulated by 
norepinephrine were found to be unaffected by cell size. The 
authors suggested these findings indicated that the number of re­
ceptors in the cell were fixed and were distributed over a greater 
area as the cell enlarged. 
The cells of cold-exposed rats (5°C) were more sensitive to 
the lipolytic action of norepinephrine than were the cells of amimals 
exposed to ambient temperatures (25°C). The increased lipolysis in 
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the adipose tissue of the cold-exposed rat was independent of cell 
size. The investigators suggested the increase may have been due 
to increased cell numbers (Therriault ^  ai., 1969; Therriault and 
Mellin, 1971). 
Hubbaxd and Matthew (1971) observed, in rat epididymaJL fat pads, 
that lipolysis stimulated by norepinephrine was proportional to fat 
cell numbers but was inhibited when cell lipid stores increased to 
over 80 percent of the total weight of the depot. 
Lipolysis stimulated by ACTH was found to increase in rat 
epididymal fat pads as the cell surface area increased (Zinder and 
Shapiro, 1971). 
Effects of Sex Hormones on Lipid Mobilization 
Several observations have indicated that testosterone and 
estrogen axe involved in lipid mobilization. Among these have been 
the chamges seen during puberty, the accumulation of fat in girls 
and the loss of subcutaneous fat in boys (Astwood, 1970a; Astwood, 
1970b). In addition, it has been known for hundreds of years that 
castration or ovcoriectomy caused fat deposition in some ainimals 
(Hausberger, 1965). Some studies have been conducted to investi­
gate the influences of these hormones on lipid mobilization. 
Androgens 
A 14 mg TP subcutsmeous implant in male mice for 34 days caused 
an increase in body weight and decreases in seminal vesicle, prostate 
and total carcass lipid content (Kochakism and Stettner, 1948). 
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Korner amd Young (1955) also found a decrease in body lipid content 
in intact male and female rats and in hypophysectomized female rats 
treated with methylandrostenediol. However, the response of body 
weights to treatment varied with the age of the animaJL. Young rats 
exhibited an increase in body weight over that observed in control 
animals, while older rats had less gain in body weight than the 
control animals. Injections of testosterone have been shown to re­
duce the thickness of subcutsoieous fat of arms and thighs of eunuchoid 
patients (Vague et , 1968) , 
Aftergood and A1 fin-Slater (1965) examined the effects of diet 
and TP on lipids in weanling male rats. Castrated animals received 
1.66 mg TP/lOO g body ^veight three times per week for 12 weeks. The 
animals received either a control diet, a fat-free diet or a choles­
terol diet. Castration caused increased weight gains, while hormone 
treated castrated animals exhibited loss of weight. Total liver 
lipids in castrated animals fed control or cholesterol diets were 
increased over the levels observed in controls. Testosterone 
treatment decreased the levels to near control values. Total liver 
lipid concentrations were unchanged in castrated and hormone treated 
animals on the fat-free diet. 
Female rats were staxved for three days and given injections 
containing 10 mg of TP per day for the last two days of starvation. 
The plasma FFA levels of these animals were increased 78 percent, 
while untreated starved rats had only a five percent increase over 
control values. The TP treated animals lost 4.2 percent of their 
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body weight, whereas the untreated animals lost 5.7 percent 
(Laoron amd Kowadlo, 1963). Laxon and Kowadlo-Silbergeld (1964) 
observed decreases in body weight aoid increases in plasma FFA 
concentrations when starved female rats were injected with 10 mg 
TP per day or with 10 mg nandrolone per day. Assuming that the 
plasma FFA concentration was an index of adipose tissue activity, 
the authors concluded that both TP and nandrolone possess lipid 
mobilizing properties. In a third study, Laoron and Kowadlo-
Silbergeld (1965b) examined the effects of TP dosage on plaama 
FFA levels and body weights of fasting animals. As the amount of 
TP injected increased, the levels of plasma FFA increased. Body 
weight losses were less in animals given high dosages of TP than 
in animals given lower dosages. When the same dosage of TP was 
administered to castrated male rats and intact female rats, higher 
plasma FFA levels were observed in the castrated males. These 
investigators also found that methandrostenolone has lipid 
mobilizing properties similax to those observed with TP. 
Nikul*cheva (1969) found higher concentrations of FFA in 
serum and in the perirenauL fat depot of fasting castrated male rats 
tham in intact controls or fasting, intact rats. When these 
animals were stressed with electrical stimulation, serum and 
tissue FFA levels in the fasting, castrated animals increased 
significcintly more than the levels observed in fasting intact 
animals. 
Premenopausal women were given 10-30 mg of methamdienone per 
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day, for one to three months. KissebaJi et al. (1973) found no 
change in either the plasma FFA levels or the FFA turnover rate 
when comparing the before treatment values with the after treat­
ment values. 
Estrogens 
Administration of alpha-estradiol or methoxybisdehydrodoisynolie 
acid to castrated mice resulted in loss of body weight or less weight 
gain than observed in control animals. Higher levels of the estro­
gens caused increased loss of body weight. Treatment also caused 
a decrease in the weights of the prostate, seminal vesicles, kidney, 
liver, and thymus (Kochakian et , 1948). 
Weanling female rats were ovariectomized and given 0.16 mg EB/ 
100 g body weight three times a week for 12 weeks. During this 
time, the animals were fed either a control diet, a fat-free diet, 
or a cholesterol diet. Ovaxiectomized smimals showed increased 
weight gains, while weight gains in the EB treated animals were de­
creased. Examination of total liver lipids in the groups fed the 
control diet and the cholesterol diet reveaJLed increased levels of 
lipids in ovaxiectomized animals, whereas EB treatment decreased 
these levels to near normal control values. The liver lipid levels 
in emimals fed the fat-free diet were unchanged by either ovariectomy 
or hormone treatment (Aftergood and Alfin-Slater, 1965). 
Sakai ^  (1970) found that castration of rats decreased 
the rate of weight gain, while ovaoriectomy caused an increase in 
weight gain. Administration of EB reduced the rate of weight gain 
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in both sexes. When the lipids of the long bones were examined, 
the authors observed a decrease in total lipids amd fatty acids 
with gonadectomy, more prominent in females than in males. How­
ever, treatment with EB increased the concentrations of totad. 
lipids cind fatty acids in both sexes. 
Ovariectomized rats fed a 1ipidosis-producing diet required 
high daily injections of estriol, 3 mg/kg and 9 mg/kg for 10 days, 
to reduce the increase in serum total fatty acids (Hess, 1964). 
No changes in serum total fatty acid levels were observed in 
ovariectomized rats treated for 29 days with lower doses of est­
riol, 0.003 mg/kg, 0.03 mg/kg, and 0.3 mg/^g, when compeared with 
control animals. 
Laron aoid Kowadlo-Silbergeld (1965a) found that treatment 
with EB induced a decrease in body weight and an increase in plasma 
FFA concentrations in both male and female fasting rats. The 
effects of EB on plasma FFA levels were dose related, a low dose 
(5 mg/day) caused a lower response than a higher dose (10 mg/day)-
When EB (5 mg/day) a^nd TP (10 mg/day) were administered together, 
a synergistic effect on plasma FFA levels was observed. However, 
the synergistic effect was not as great as the response observed 
when the dosage of EB was doubled. This led the investigators to 
conclude that EB may be a more potent lipid mobilizing agent tham 
TP. 
Male rats given 1.7 mg EB daily for five days exhibited a 
marked decrease in plasma totaJL lipids, while the plasma FFA 
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concentration was unchanged from control values. Liver total lipids 
were unchanged by this treatment, vdiile liver FFA levels were sig­
nificantly decreased. Heart total lipids and FFA levels were un­
affected by EB administration (Fewster et , 1967). 
During pregnancy, when estrogen levels were high, human serum 
total lipids and FFA levels increased progressively with each tri­
mester and decreased to near normal, non-pregnant levels by one 
week postpairtum (DeAlvéïrez et a2., 1967). Furman (1969) reported 
higher plasma FFA levels in postmenopausal women than in men or 
premenopausal women, while levels in premenopausal women were higher 
than in men. 
Wynn and Doax (1966) examined the effects of oral contraceptive 
pills on plasma lipid levels in women treated for more than three 
months. Plasma FFA concentrations in treated women were elevated 
above the levels recorded for control subjects. In a more recent 
study, Larsson-Cohn al, (1970) observed a decrease in plasma FFA 
concentrations in women treated for 48 weeks with one brand of 
contraceptive and variable FFA levels in women taking three differ­
ent bramds. 
Estrogen has been reported to stimulate secretion of insulin, 
growth hormone, and adrenal cortex hormones. There has been specula­
tion that these hormones may be responsible for lipid changes seen 
in women treated with estrogen (Spellacy et 1969; Alfin-Slater 
and Aftergood, 1971). 
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Summary 
No concrete conclusions can be drawn concerning the effects of 
sex hormones on thyroid gland activity even though the subject has 
been well researched. The results vary with the assay techniques, 
the strain, age and sex of the animal, the type and dosage of hor­
mone, and the length of time the animal received treatment. It 
seems likely that testosterone and estrogen are only two of the 
many factors which combine to regulate thyroid activity and that 
the effectiveness of these hormones in changing thyroid activity 
would vary with the conditions mentioned above. 
Because the study of adipose tissue cellulaxity is in its 
infancy, the number of factors known to alter cell number aire 
limited. In general, adipose tissue cell number vaories with the 
location of the depot and with the age, sex, and strain of animal 
examined. The number of cells found in a particular depot can be 
altered, but only if cerxain factors in the internal or external 
environment of the animaJ. sire changed early in life. 
Lipid mobilization appeaurs to be affected by the number and 
size of fat cells in adipose tissue. The basal rate of lipolysis 
in the tissue seems to increase as cell number increases. How­
ever, the rate of lijxjlysis per cell may change with cell size. 
Reports in this area are conflicting. Many studies indicate that 
large cells have a higher rate of hormone stimulated lipolysis than 
small cells, whereas a few reseairchers report the increased rate 
of hormone stimulated lipolysis is independent of cell size. 
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Gonadectomies result in am increase in the rate of weight gain, 
while replacement therapy with either testosterone or estrogen de­
crease the rate of gain. Plasma FFA levels can be increased by 
administration of testosterone or estrogen. The reports suggest 
these hormones induce mobilization of lipids from adipose tissue. 
On the other haind, some studies report that plasma FFA levels in­
crease after gonadectomies aoid that estrogen therapy in intact or 
ovajriectomized animals or humems lowers the levels of plasma FFA. 
The differences in diet and the type and amount of hormone admin­
istered may be responsible for these discrepancies. 
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METHODS AND MATERIALS 
Treatment of Animals 
Male rats of the Sprague-Dawley-Sasco strain were used in this 
study. The animals were maintained in community cages, with seven 
to eight animals per cage, and fed Wayne Lab Blox and water ad 
libitum. The animal room in which the animals were housed, prior 
to and during treatment, was temperature controlled (24°C ± 3°C) 
with a fourteen hour photoperiod (lights on: 0800; lights out: 
2200). 
Experimental. Treatment 
The animals were divided into four groups: normal, intact, 
control aoiimals; castrated aunimals, no hormonal treatment; cas­
trated animals injected with testosterone propionate (TP); and 
castrated amimals injected with estradiol benzoate (EB). The 
orchidectomy (Appendix A) was performed when the animals were 55 
days old. A two week recovery period after surgery was allowed 
before hormonal treatments were initiated. 
Testosterone propionate and estradiol benzoate were dissolved 
in corn oil to a dose concentration of 0.6 mg/0.1 ml/rat and 1.0 jjg/ 
0.1 ml/rat, for injection into the TP and EB groups, respectively 
(Appendix B). This dosage of TP was used because it maintains 
accessory reproductive organ weights in castrated rats (Zaxrow et 
al., 1964b). The EB dosage was chosen because it maintains mammary 
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gland growth in ovaxiectomized rats (Moon ^ t , 1959). The 
control and castrate groups were injected only with 0.1 ml of the 
vehicle. Single injections were given daily, subcutaneously, for 
10 weeks. Twenty-four hours prior to sacrifice of the animals, 
injections were discontinued. 
Thyroid Hormone Secretion Rate 
The thyroid secretion rate (TSR) was determined by the iodine-
131-thyroxine substitution method (Anderson, 1969) (Appendix C). 
The TSR of each animal was measured prior to surgical intervention 
and hormonal treatment. A final TSR was determined aifter seven 
weeks of hormonal treatment. 
Handling of Tissues 
After 10 weeks of hormonal treatment and 12 hours of fasting, 
the animsuLs were sacrificed by decapitation. Blood was collected 
in glass centrifuge tubes, allowed to coagulate at room temperature 
for approximately four hours, and then refrigerated overnight. The 
cooled, coagulated blood was centrifuged the next morning. Serum 
was removed, frozen, and stored in one dram vials at -20°C (Nelson, 
1970). 
The retroperitoneal fat depots were rapidly removed after 
death. Two 100-200 mg portions were cut from the left fat depot 
and weighed. One portion was incubated in a 25 ml erlenmeyer flask 
containing 4.0 ml of Krebs-Ringer bicarbonate medium (IMbreit et , 
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1949) and 40 mg/ml of albumin, at pH 7.4, for FFA release from 
the tissue (Appendix D). The second portion of tissue was in­
cubated in a plastic test tube containing 3.0 ml of Krebs-Ringer 
bicarbonate medium, 40 mg/ml of albumin, 10 mg/ml of collagenase, 
and 3.0 |jmoles/ml of glucose, at pH 7.4, for liberation of fat 
cells for cell size determination (Rodbell, 1964; DiGirolamo et al., 
1971) (Appendix D). Prior to incubation, the vessels were flushed 
with a gaseous mixture of 95% - 5% CO^ for one minute. The 
vessels were then sealed and the incubations caxried out for one 
hour at 37°C in a shaker. 
After the removal of the two portions of tissue for incubation, 
the remainder of the retroperitoneal fat depot was placed in a 
chloroform : methanol solution for extraction to yield total lipids 
and dry fat-free tissue (DFFT). 
Hie adrenal glands and seminal vesicles of each animal were 
removed and cleaned of all connective tissue^ fat, and secretions 
before weighing. 
Extraction and Assay of Free Fatty Acids 
Released from Retroperitoneal Adipose Tissue 
Sarûples of the FFA incubation medium taken before and after in­
cubation were extracted by the method of Dole (1956) and Dole and 
Meinertz (1960) (Appendix E). The resulting heptane solutions of 
FFA were tightly sealed in one dram vials and stored at -20°C 
(Nelson, 1970). 
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Determination of the FFA levels in the heptane solutions was 
accomplished using nickel-63 as a tracer by the method described by 
Ho (1970) (Appendix F). Because of the low levels of FFA encountered 
in the incubation extractions, the specific activity of the ^^Ni was 
increased as suggested by Ho (1970) for serum FFA determination (Ap­
pendix F). A standard curve was used to convert the sample counts 
per minute (cpm) to pinoles FFA. The (jmoles of FFA in the before in­
cubation extraction were subtracted from the pjaoles FFA in the after 
incubation extraction, to give the actual level of FFA released from 
the sample of the retroperitoneal fat depot of each animal. Each 
sample was assayed in duplicate. 
Serum Free Fatty Acid Extraction and Assay 
The FFA were extracted from serum samples and assayed according 
to the method of Ho (1970) (Appendix F). A standard curve was used 
to convert cpm to umoles FFA. Each sample was assayed in duplicate. 
Cell Size De terminât ions 
The incubation medium containing the liberated fat cells was 
centrifuged for one minute at 400 g. Since the fat cells floated 
to the surface, the stromal-vasculax cells were removed by aspira­
tion (Rodbell, 1964) aJ.ong with most of the incubation medium. The 
fat cells were washed by suspension in Millonig's phosphate buffer, 
pH 7.4 (Millonig, 1961; Lumsden et , 1965). After gentle agita­
tion, the cells were centrifuged aoid again most of the buffer re­
moved by aspiration. This procedure was performed twice. After the 
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second washing and removal of the buffer, 5.0 ml of 1% osmium 
tetraoxide in Millonig's phosphate buffer (Appendix G) was added 
to the fat cells. 
After fixation, the fat cells were filtered from the osmium 
solution according to the method of Hirsch and Gallian (1968). 
The fat cells were stored in physiological saline until the cell 
diameters could be measured. 
The diameters of 300 free fat cells per animal were measured 
using a Prado (Leitz) micro projector. The images of fat cells 
were projected on to graph paper which had been calibrated with a 
stage micrometer. The cells were measured to the neaorest five 
microns. From these measurements, the surface area and volume of 
the fat cells were determined by the method of DiGirolamo et al. 
(1971). 
This method of liberating and fixing fat cells for cell size 
detezrmination vjas developed for economic reasons, by combining 
the methods of DiGirolamo e_t (1971) and Hirsch and Gallian 
(1968). 
Dry Fat-Free Tissue, Total Lipids, 
and Lipid Density Determinations 
The retroperitoneal fat depots were defatted using two 24-hour 
extractions, with 50 ml of a chloroform : methanol solution (2:1, 
v:v), for each extraction. This was followed by two 24-hour ex­
tractions with 50 ml of aoihydrous ether for each extraction. The 
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jars containing the tissue and solvents were subjected to const am t 
agitation on a shaker at room temperature. After the last ex­
traction procedure, the tissue was removed, air dried for several 
days, and oven dried (50°C) to remove all moisture. The resulting 
DFFT was then weighed. 
The solvents used to extract total lipids from the retroperi­
toneal fat depots were allowed to evaporate, leaving the lipid 
residue. This residue was redissolved in the chloroform : methaoiol 
solution (2:1, v:v), centrifuged, filtered through a 25 |j nylon 
screen, and the solvents again allowed to evaporate. The lipid 
residues were then placed in desiccator jars containing anhydrous 
CaSO^ to remove all moisture. Total lipids and lipid densities 
were determined by the microgravimetric method of DiGirolamo et al., 
(1971). 
Cell Number Determinations 
Utilizing the data obtained for cell volumes, lipid densities, 
and total lipids, the total number of cells per tissue was calculated 
(DiGirolamo et ^ ., 1971) . 
Analysis of Data 
Data analyses were caxried out with the aid of Dr. David Cox 
aind the Department of Statistics, Iowa State University. The 
procedures used were those of the Statistical Analysis System (Bairr 
and Goodnight, 1971; Service, 1972). Calculations included means. 
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analysis of vaxiance (ANOV), least significant differences (Isd), 
and correlation coefficients. 
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RESULTS AND DISCUSSION 
To facilitate reporting, the data will be divided into three 
subsections: thyroid secretion rates, adipose tissue cellularity, 
cind lipid mobilization. The means, standard error of the means, 
least significant differences (Isd) and amalysis of variance (ANOV) 
for each set of data will be included in the appropriate subsection, 
while correlation coefficients will be presented in table form at 
the end of the discussion. 
Thyroid Secretion Rates 
The initial TSR, final TSR, and the difference between these 
two variables are presented in Table 1 and graphically represented 
in Figure 1. 
The initial TSR for the control, castrate, testosterone 
propionate treated (TP) and estradiol benzoate treated (EB) animals 
were not significantly different (Table 2). This was expected 
since the four groups were homogeneous at the beginning of the ex­
perimental period. 
The final TSR for the control, castrate, and EB animals did 
not differ significaaitly. Whereas, the TSR of the TP animals were 
significauntly increased (P < 0.01) over the TSR of the other three 
groups. This was verified by the ANOV in Table 3. 
The difference TSR, generated by subtracting the initial TSR 
from the final TSR, was a better measurement of the actual chamges 
occurring during treatment because it was reasonably independent 
Table 1. Thyroid secretion rates before and after treatments and differences between 
these variables 
Least 
significant 
Groups Control Castrate TP EB difference 
at p < 0.01 
L-T^/lOO g B.W./day 
Initial TSR. 1.11 ± .08* 1.04 ± .08 1.18 ± .09 0.98 ± .05 0.26 
Final TSR 1.14 ± .07 1.00 ± .09 1.55 ± .07 1.12 ± .08 . 0.27 
Difference TSR 0.04 ± .10 -0.04 ± .11 0.37 ± .11 0.13 ± .07 0.36 
*Mean ± standard error of the mean. 
Figure 1. Thyroid secretion rates of control, castrate, testosterone 
propionate treated (TP) , aind estradiol benzoate treated (BB) 
sinimals. Itie opten bars represent the TSR before treatment 
and shaded bars represent the TSR after treatment. 
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Table 2. Analysis of vaxiance for thyroid secretion rates before 
treatment 
Source d.f. Mean square F value Prob > F 
Between groups 0.1126 1.54 0.2125 
Within groups 
(error) 
54 0.0729 
Table 3. Analysis of variemce for thyroid secretion rates after 
treatment 
Source d.f. Mean squaare F value Prob > F 
Between groups 0.8482 10.85 0.0001 
Within groups 
(error) 
54 0.0782 
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of the initial amd final values. The difference TSR in the TP 
treated animals was significantly higher (p < 0.01) than in the 
castrate group. There were no significant differences among the 
difference TSR of TP, EB, and control animals nor among the control, 
castrate aind EB ajiimals. The ANOV in Table 4 shows the difference 
TSR were significantly affected by treatment (p < 0.0276). 
The finding in the present study that castration does not 
change the TSR is similar to the report by Kochakieui and Evams 
131 (1956), which indicated no change in I uptake in castrated rats. 
The present study is in disagreement with the reports of decreased 
thyroid activity due to decreased TSH levels in castrated rats 
(Van Rees et , 1965; D'Angelo, 1966) and of a 12 percent decrease 
in the TSR (Kumcaresaoi and Turner, 1967a). However, in this study, 
a 12 percent decrease would not have been significant. 
Table 4. Analysis of variance for differences between thyroid 
secretion rates before and after treatment 
Source d.f. Mean square F value Prob > F 
Between groups 3 0.4497 3.27 0,0276 
Within groups 54 0.1376 
(error) 
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The finding that TP increases the TSR is in agreement with the 
results of Van Rees ejt (1965) and Kumaxesan and Turner (1967a) . 
Whereas, the observation that EB treatment does not significantly 
alter the TSR is supported by Paschkis et a^, (1948) and Grosvenor 
ajid Turner (1959). 
Adipose Tissue Cellulaxity 
Body weights of the four groups during the ten weeks of treat­
ment axe presented in Table 5 and in Figure 2. As can be seen, no 
significant differences were appsurent before treatment nor after 
one week of treatment. After two weeks of treatment, significant 
differences (p < 0.01) appeared between the EB treated animals and 
the control group. By the end of the third week of treatment, the 
body weights of both the TP and EB groups were significantly (p < 
0.01) less than those observed in the control group. These dif­
ferences continued throughout the treatment period. After four 
weeks of treatment, the body weights of the EB treated animals 
were significantly lower (p < 0.01) than those of the castrate 
group. These differences also continued throughout the treatment 
period. By the seventh week of treatment, body weights of castrate 
animals were significantly lower (p < 0.01) than those of the 
control animals. These differences were observed only sifter the 
seventh aind eighth week of treatment. Body weights of TP treated 
animals were significantly lower (p < 0.01) than those of castrate 
cLnimals only after the seventh and ninth week of treatment. The 
Table 5. Body weights during ten weeks of treatment 
Groups Control Castrate TP 
Weeks of treatment grams 
Initial 326,0 ± 8.3* 301.0 ± 6,0 308.0 ± 6,4 323,0 ± 7,4 26,12 
1 3X17.0 ± 9.0 327.0 ± 5.9 347.0 ± 7,0 326,0 ± 7,7 27,74 
2 366,0 ± 9.0 346.0 ± 5,8 351,0 ± 7,7 330,0 ± 7,9 28,59 
3 387.0 ± 9.5 363.0 ± 6,0 353,0 ± 9,4 338,0 ± 8.5 31,53 
4 403.0 ± 9.7 375.0 ± 6,1 360,0 ± 9,8 341,0 ± 8,4 32,28 
5 416.0 ± 9.9 389.0 ± 6,4 361,0 ±10,5 348,0 ± 8,6 33,53 
6 431,0 ±10.8 399.0 ± 6,4 369,0 ±: 10,2 348,0 ± 8,8 34,38 
7 437.0 ±11.0 400,0 ± 6,4 367.0 ± 9.7 346.0 ± 8,0 33,15 
8 440.0 ±11.0 401,0 ± 6,7 369.0 ± 9.3 350,0 ± 8,2 33.06 
9 432.0 ±10.8 407,0 ± 7,4 372.0 ± 9,0 353,0 ± 8,0 32,89 
10 425,0 ±14,5 409,0 ± 8,0 375.0 ± 9.3 354,0 ± 8,2 38,00 
Final 426,0 ±14.3 408,0 ± 8,0 373.0 ± 9,3 351,0 + 8,5 38,04 
Least 
significant 
difference 
at p < 0,01 
*Mean ± standard error of the mean. 
Figure 2. Body weights of control, castrate, testosterone propionate 
treated (TP), and estradiol benzoate treated (EB) rats 
during ten week» of treatment. 
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ANOV shows body weights were significantly affected (p < 0.01) by 
treatments amd weeks of treatments (Table 6). 
The finding that TP and EB decrease body weight gains is in 
agreement with the reports of Aftergood and A1fin-Slater (1965) 
and Sakai et (1970). However, the observed decreases in weight 
gains in castrate animals were in disagreement with the findings of 
Aftergood and Alfin-Slater (1965). The decrease in body weight 
gains in the castrate animals may have been due to treatment with 
the corn oil vehicle. Zaxrow et al. (1964a) have found many 
vegetable oils to have slight estrogenic properties. 
Retroperitoneal adipose depot, seminal vesicle, and adrenal 
gland weights for each group aire given in Table 7. The control 
Table 6. Analysis of variance for body weights during ten weeks 
of treatment 
Source d.f. Mean square F value Prob > F 
Group 3 127071. ,33 
Animal 54 11369. 26 
Week 10 20351. 65 
Week-Treatment 30 2102. 87 16.00 0.01* 
Error 540 135. 46 
^Conservative degrees of freedom used. 
Table 7. Retroperitoneal adipose depot, seminal vesicle, and adrenal gland weights 
after treatments 
Groups Control Castrate TP EB 
Least 
significant 
difference 
at p < 0.01 
Retroperitoneal 5,,058 ± .719* 5.397 ± .440 2.393 ± .223 3.361 ± .235 1.633 
fat depots (g) 
Seminal Ou332 ± .012 0.048 ± .002 0.542 ± .011 0.052 ± .002 0.031 
vesicles (g) 
Adrenal 0,.050 ± .001 0.061 ± .002 0.046 ± .002 0.065 ± .002 0.007 
glands (g) 
*Mean ± standard error of the mean. 
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and castrate animals had signifleantly laorger (p < 0.01) fat depots 
than the TP and EB treated aoiimals. There were no significant dif­
ferences between control and castrate animals nor between TP and 
EB treated animais. The ANOV in Table 8 indicates treatments had 
significant effects (p < 0.0001) on the weights of the retroperi­
toneal fat depots. 
Seminal vesicle weights of castrate and EB treated animals 
were significantly lower (p < 0.01) thain those of control and TP 
treated emimals. Weights of seminal vesicles from TP treated 
amimals were significantly larger (p < 0.01) than those of the 
control group. There were no significant differences in seminal 
vesicle weights in the castrate and EB groups. The ANOV confirmed 
the significant effects (p < 0.0001) of treatments on seminal 
vesicle weights (Table 9). 
Adrenal glands from control and TP treated sunimaJLs were sig­
nificantly smaller (p 0.01) than the glands £xom castrate and ES 
treated groups. There were no significant differences between the 
control amd TP treated animals nor between the castrate and EB 
treated animals. The significant effects of treatments (p < 0.0001) 
on adrenal gland weights are shown in Table 10. 
As expected, the retroperitoneal adipose depot weights were 
positively correlated with the final body weights (r = 0.6869, 
p< 0.0001) (Table 23). Significant physiological relationships 
were also found between the final TSR and the weights of the 
retroperitoneal fat depot, seminal vesicles, and adrenal glands. 
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Table 8. Analysis of vajriance for retroperitoneal adipose depots 
weights 
Source d.f. Mean square F value Prob > F 
Between groups 3 29.295 10.45 0.0001 
Within groups 54 2.804 
(error) 
Table 9. Analysis of variance for seminal vesicles weight 
Source d.f. Mean squaore F value Prob > F 
Between groups 
Within groups 
(error) 
3 
54 
0.84319786 854.28 0.0001 
0.00098702 
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Table 10. Analysis of vairiance for adrenal gland weights 
Source d.f. Mean square F value Prob > F 
Between groups 3 0.00117267 26.20 0.0001 
Within groups 54 0.00004476 
(error) 
The r values are -0.5046 at p < 0.0002, 0.5348 at p < 0.0001, 
and -0.3997 at p < 0.0022. Thus, as the TSR increase, the weights 
of the fat depot smd adrenal gland decrease and seminal vesicle 
weights increase. 
Since seminaJL vesicles sure very sensitive to TP levels, the 
weights were recorded primairily to monitor the effects of the TP 
dosage used. Larger seminal vesicles in the TP treated animals 
than in the control animals indicates that the dosage used (0.6 
mg/day) was above physiological levels. 
Injections of TP maintained the weights of adrenal glands 
at a level similar to that observed in control animauLs. However, 
the gland weights were higher in the castrate and EB groups. This 
could indicate increased secretory activity by the gland or increased 
release of ACTH. 
Table 11 presents the data for retroperitoneal adipose cell 
Table 11. Cell diameter, surface area, volume and number in retroperitoneal fat depots 
after treatment 
Groups Control Castrate TP EB 
Least 
significant 
differences 
at p < 0.01 
Diameter (|a) 67.8 ± 3.7* 74,2 ± 2.7 68.4 ± 1.6 66.1 ± 1.4 9.1 
Surface area 17.23 ± 1.79 19.86 ± 1.31 15.97 ± 0.72 15.25 ± 0.56 4.31 
3 3 
Volume (|a .10 ) 2(34 . 96 ±38.89 310.96 ±27.93 210.73 ±13.70 201.41 ±10.16 91.36 
Number x 10^ 18.88 ± 2.50 18.66 ± 2.84 8.89 ± 0.74 14.58 ± 1.12 7.25 
*Mean ± standard error of the mean. 
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diameter, surface area, volume, and number. Fat cell diameters 
of the four treatment groups did not differ significantly from each 
other at the one percent level. Table 12 showing the ANOV confirms 
this finding. 
The surface areas of fat cells from the castrate smimaULs were 
significantly larger (p < 0.01) thsm the surface areas of cells 
from EB treated animals. There were no significant differences in 
cell surface area among control, castrate and TP treated animal s nor 
among the control, TP, and EB groups. The effects of treatment on 
fat cell surface area were not highly significamt (Table 13). 
Fat cell volumes were significemtly laxger (p < 0.01) in 
castrate amimals thaji in TP and EB treated groups, but were not 
significantly different from those in control animals. Fat cell 
volumes observed in control, TP, aind EB adipose tissue were not 
significantly different. The ANOV presented in Table 14 shows that 
fat cell volume was significantly affected by treatment. 
The number of fat cells contained in the retroperitoneal fat 
depot of TP treated animals was significantly smaller (p < 0.01) 
than the number found in the fat depots of control and castrate 
animals. There were no significant differences in fat cell number 
aimong the control, castrate and EB treated groups nor between the 
TP and EB treated animals. The finding that treatment significemtly 
affected fat cell number is supported by the ANOV in Table 15 (p < 
0.0020). 
The data for total lipids, lipid density, amd DFFT from the 
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Table 12. Analysis of variance for retroperitoneal fat cell 
diameters 
Source d.f. Mean square F value Prob > F 
Between groups 3 175.0562 2,02 0.1204 
Within groups 54 86.5751 
(error) 
Table 13. Analysis of variance for retroperitoneal fat cell 
surface area 
Source d.f. Meain squaxe F value Prob > F 
Between groups 3 58.99 3.01 0.0371 
Within groups 54 19.58 
(error) 
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Table 14. Analysis of vaariamce for retroperitoneal fat cell 
volume 
Source d.f. Mean square F value Prob > F 
Between groups 3 37526.58 4.27 0.0090 
Within groups 54 8781.69 
(error) 
Table 15. Analysis of vaariamce for retroperitoneal fat cell number 
Source d.f. Mean square F value Prob > F 
Between groups 3 319.77 5.78 0.0020 
Within groups 54 55,29 
(error) 
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retroperitoneal fat depots are presented in Table 16. Fat depots 
from control and castrate animals contained significantly more 
lipids (p < 0.01) tham the fat depots of the TP and EB treated 
groups. No significant differences in total lipids were found 
between control and castrate animals nor between the TP and EB 
treated animals. The significant effects of treatments on total 
lipids from the retroperitoneal fat depot are verified by ANOV 
(Table 17). 
The densities of lipids contained in the retroperitoneal fat 
depot of castrate eind EB treated animals were significantly lower 
(p < 0.01) than those observed in control amimals. Lipid densi­
ties were also lower, (p < 0.01) in the EB treated group than in 
the TP treated group. However, there were no significant differences 
between lipid densities of control and TP treated animals nor be­
tween castrate and EB treated animals. The effect of treatments on 
lipid density was significant at p < 0.0001 (Table IS). 
The amount of DFFT in the retroperitoneal fat depots of TP and 
EB treated ainimals was significantly less (p < 0.01) thain the DFFT 
levels in control animals. There were no significant differences 
in DFFT weights between control and castrate ainimals nor between 
TP and EB treated amimals. The ANOV (Table 19) indicates that 
treatments had a significamt effect on DFFT weights. 
To briefly smnmaarize these data, the smallest retroperitoneal 
fat depot, found in the TP treated animals, contained fewer fat 
cells of smaller volume than the depots of control and castrate 
Table 16. Total lipids, lipid density and DFFT from retroperitoneal fat depots 
Groups Control Castrate TP EB 
Least 
significant 
difference 
at p < 0,01 
Total lipids (g) 4.,840 ± .849* 5.169 ± .572 1.924 ± .216 2.860 ± .218 1.925 
Lipid density 1..017 ± .002 1.003 ± .003 1.015 ± .002 0.990 ± .006 0.014 
(g/ml) 
DFFT (g) 0..083 ± .013 0.067 ± .005 0.046 ± .003 0.052 ± .003 0.027 
*Mean ± standard error of the raeeoi. 
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Table 17. Analysis of variance for total lipid weight in retro­
peritoneal. fat depots 
Source d.f. Mean square F value Prob > F 
Between groups 3 35.3941 9.08 0.0002 
Within groups 54 3.8995 
(error) 
Table 18. Analysis of variance for lipid density of lipids from 
retroperitoneal fat depots 
Source d.f. Mean square F vaJ.ue Prob > F 
Between groups 3 0.0023088 11.86 0.0001 
Within groups 54 0.0001946 
(error) 
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Table 19. Analysis of variance for DFFT from retroperitoneal 
fat depots 
Source d.f. Mean square F value Prob > F 
Between groups 3 0.003866 5.20 0.0035 
Within groups 54 0.000743 
(error) 
animals. The fat depots of the TP group also contained the smallest 
amount of total lipids. The fat cell volumes in the fat depots of 
EB treated animals were slightly smaller than those of the TP 
treated animals. Despite this fact, the slightly larger fat depot 
of the EB treated animals contained more total lipids them the TP 
group because of the larger number of fat cells present. The larger 
retroperitoneal fat depots of the control and castrate animals con­
tained the laorgest number of cells with larger fat cell volume and 
more total lipids. The fat depots of the castrate group contained 
slightly more total lipids than the control group fat depots, be­
cause of slightly larger fat cell volume. The depots of TP and EB 
treated animals contained smaller amounts of DFFT than the depots 
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of control and castrate groups. 
These observations are confirmed by correlation coefficients 
(Table 23) which indicate positive physiological relationships be­
tween the retroperitoneal fat depot smd total lipids, DFFT, cell 
diameter, cell surface area, cell volume, and cell number. The r 
values are 0.9922 at p < 0.0001, 0.8625 at p < 0.0001, 0.4270 at 
p < 0.0012, 0.5430 at p < 0.0001, 0.6267 at p < 0.0001, and 0.6745 
at p < 0.0001, respectively. PhysiologicaJL relationships were also 
found between totaJ. lipids and DFFT, cell diameter, cell surface area, 
cell volume and cell number. Respective correlation coefficients are 
0.8835 at p < 0.0001, 0.4176 at p < 0.0015, 0.5312 at p < 0.0001, 
0.6138 at p < 0.0001, and 0.6608 at p < 0.0001. Positive relation­
ships also exist between DFFT and cell diameter, cell surface area, 
cell volume, and cell number. The r values are 0.3615 at p < 0.0055, 
0.4511 at p < 0.0006, 0.5158 at p < 0.0001, and 0.5284 at p < 0.0001. 
The final body weight is positively correlated with total lipids, 
DFFT, cell diameter, cell surface area, cell volume and cell number. 
The r values are 0.6765 at p < 0.0001, 0.7079 at p < 0.0001, 0.3601 
at p < 0.0056, 0.4365 at p < 0.0009, 0.4915 at p < 0.0002, and 
0.4330 at p < 0.0010. In general, when the final body weights, 
retroperitoneal fat depot weights, total lipids cind DFFT weights 
increase, there are also increases in cell diameter, cell surface 
area, cell volume and cell number. Significant physiological, re­
lationships exist between the final TSR and total lipids and fat 
cell number. The r values are -0.4825 at p < 0.0003 axid -0.4810 
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at p < 0.0003. This indicates that as TSR increase, the amount of 
total lipids and number of fat cells decrease in the retroperitoneal 
fat depot. 
The lipid densities reported here axe higher than those ob­
served by DiGirolamo et (1971). The higher values may indicate 
larger proportions of glycerol, monoglycerides and diglycerides than 
of triglycerides in the total lipids. 
The most unexpected finding of this study was that TP treat­
ment reduced fat cell numbers in the retroperitoneal fat depot. 
Fat cell numbers were also reduced by EB treatment, but not to a 
significaoit degree. Cell division in rat epididymal fat pads has 
been reported to cease by nine weeks (Hubbard aoid Matthew, 1971), 
14 weeks (Johnson et , 1971), and 15 weeks of age (Hirsch said 
Han, 1969). Sexual maturity in the rat stairts at approximately 
6-7 weeks of age. Testosterone secretion probably reaches adult 
levels someTime between the ages of 9-15 weeks. Thus, testosterone 
may be at least paortially responsible for inhibiting cell division 
in adipose tissue under normal conditions. However, studies show­
ing that nutrition (Knittle and Hirsch, 1968), exercise (Oscai ^  
al., 1972), cold exposure (Therriault et , 1969), and human 
growth hormone (Knittle et , 1971) affect fat cell numbers 
indicate other factors are involved in the mechanism controlling 
the number of cells making up an adipose tissue depot. 
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Lipid Mobilization 
The rate of release of FFA from the retroperitoneal, fat depot 
and serum FFA concentrations are given in Table 20 and illustrated 
in Figures 3 and 4. The TP treated animals released significantly 
higher levels (p < 0-01) of FFA than the control, castrate and EB 
stnimals. There were no significant differences in the rate of FFA 
release from the fat depots of control, castrate and EB treated 
emimals. The ANOV confirmed the significant effects of treatments 
on FFA release from the fat depot (Table 21). 
Significantly lower concentrations (p < 0.01) of serum FFA 
were observed in TP and EB treated animals than in the control aoid 
castrate smimals. There were no significsmt differences between 
the TP and EB treated animals nor between the control and castrate 
groups. Hormonal treatments had a significaint effect on serum FFA 
levels as shown by ANOV (Table 22). 
The rate of release of FFA from the retroperitoneal fat depot 
was significantly related to the final TSR, final body weight, 
retroperitoneal fat depot weight, seminal vesicle weight, adrenal 
gland weight, total lipids, DFFT, and fat cell number. The r 
values are 0.4456 at p < 0.0007, -0.3757 at p < 0.0039, -0.6351 
at p < 0.0001, 0.5536 at p < 0.0001, -0.4347 at p < 0.0010, -0.6053 
at p < 0.0001, -0.4744 at p < 0.0004, and -0.6639 at p < 0.0001 
(Table 23). In general, as the rate of FFA release increased, the 
body weight, retroperitoneal fat depot weight, adrenal gland weight, 
total, lipids, DFFT, and fat cell number decreased. While FFA 
Table 20. Free fatty acid release from the retroperitoneal fat depot and serum FFA levels 
Groups Control Castrate TP EB 
Least 
significant 
difference 
at p < 0,01 
lamoles FFA/ 0,131 ± .017* 0.110 ± .016 0.253 ± .024 0.134 ± .018 
cell*10^/hr 
.072 
lamoles FFA/ml 0,832 ± .023 0.814 ± .016 0.718 ± .035 0.665 ± .016 .089 
*Mean ± standsucd error of the meam. 
Figure 3. Free fatty acid release from the retro­
peritoneal. fat depots of control, castrate, 
testosterone propionate (TP) treated, said 
estradiol benzoate (EB) treated animals. 
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Figure 4. Servun free fatty acid concentrations in 
control, castrate, testosterone propionate 
(TP) treated, aind estradiol benzoate (EB) 
treated animals. 
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Table 21. Analysis of variance for FFA release from retro­
peritoneal fat depots 
Source d.f. Meaai square F value Prob > F 
Between groups 3 0.06207 11.45 0.0001 
Within groups 54 0.GO542 
(error) 
Table 22. Analysis of variance for serum FFA concentrations 
Source d.f. Mean square F value Prob > F 
Between groups 3 0.091084 10.98 0.0001 
Within groups 54 O.008296 
(error) 
Table 23. Correlation coefficients for all variables (N=58) 
ITSR^ FTSR^ TSRD*^ FBW^ RFP® SV^ AG^ TL^ 
ITSR 1.0000* .2103 -.5132 -.1410 -.1843 .2658 -.2716 -.1694 
.0000** .1091 .0001 .2911 .1627 .0412 .0369 .2008 
FTSR .2103 1.0000 .7311 -.2016 -.5046 .5348 -.3997 -.4825 
.1091 .0000 .0001 .1252 .0002 .0001 .0022 .0003 
TSRD -.5132 .7311 1.0000 -.0786 -.3144 .2840 -.1614 -.3054 
.0001 .0001 .0000 .5644 .0154 .0289 .2239 .0187 
FBW -.1410 
.2911 
-.2016 
.1252 
-.0786 
.5644 
1.0000 
.0000 
.6869 
.0001 
.0757 
.5791 
-.1067 
.5690 
.6765 
.0001 
RFP -.1843 
.1627 
-.5046 
.0002 
-.3144 
.0154 
.6869 
.0001 
1.0000 
.0000 
-.3217 
.0132 
.2552 
.0503 
.9922 
.0001 
SV .2658 
.0412 
.5348 
.0001 
.2840 
.0289 
.0757 
.5791 
-.3217 
.0132 
1.0000 
.0000 
-.7590 
.0001 
-.2840 
.0289 
AG -.2716 
.0369 
-.3997 
.0022 
-.1614 
.2239 
-.1067 
.5690 
.2552 
.0503 
-.7590 
.0001 
1.0000 
.0000 
.2341 
.0734 
TL -.1694 
.2008 
-.4825 
.0003 
-.3054 
.0187 
.6765 
.0001 
.9922 
.0001 
-.2840 
.0289 
.2341 
.0734 
1.0000 
.0000 
^Initial TSR. 
Final TSR. 
.Differences between initial and final TSR. 
^inal body weight. 
Retroperitoneal fat pad. 
Seminal vesicle weight. 
^Adrenal gland weight. 
.TotaJL lipids. 
^ipid density. 
^ry fat-free tissue. 
^at cell diameter. 
Fat cell surface aarea. 
™Fat cell volume. 
^Fat cell number. 
Serum free fatty acids. 
^Free fatty ac ids/cell«10^. 
*Correlation coefficient. 
**Probability of a greater R under HO:RH0=O. 
65 
LD^ DFFT^' FCD^ FCSA^ FCV^ FCN^ SFFA° FFAC^ 
-.1532 
.2496 
-.2528 
.0525 
-.1151 
.6060 
.3044 
.0190 
.2396 
.0667 
-.0021 
.9847 
.1935 
.1419 
-.0978 
.5283 
.5190 
.0001 
-.5535 
.0001 
-.0558 
. 0808 
.7079 
.0001 
.8625 
.0001 
—.0676 
.6199 
.1241 
.6441 
.8835 
.0001 
-.1480 
.2669 
-.1225 
.6377 
-.0043 
.9730 
.3601 
.0056 
.4270 
.0012 
-.0728 
.5938 
.0038 
.9758 
.4176 
.0015 
-.1383 
.3009 
-.1935 
.1418 
-.0734 
.5908 
.4365 
.0009 
.5430 
.0001 
-.1161 
.6107 
.0348 
.7912 
.5312 
.0001 
-.1154 
.6076 
-.2451 
.0604 
-.1347 
.3145 
.4915 
.0002 
.6267 
.0001 
-.1413 
.2900 
.0514 
.7034 
.6138 
.0001 
-.1664 
.2093 
-.4810 
.0003 
-.3062 
.0184 
.4330 
.0010 
.6745 
.0001 
-.3306 
.0109 
.2851 
.0283 
.6608 
.0719 
.5980 
-.1536 
.2481 
-.1851 
.1608 
.3158 
.0150 
.3787 
.0037 
.0432 
.7461 
-.0195 
.8790 
.3771 
.0038 
.2498 
.0555 
.4456 
.0007 
.2168 
.0983 
-.3757 
.0039 
-.6351 
.0001 
.5536 
.0001 
-.4347 
.0010 
-.6053 
Table 23. (continued) 
ITSR FTSR TSRD FBW RFP SV AG TL 
LD .3044 
.0190 
.2396 
.0667 
.0021 
.9847 
,1934 
.1419 
.0978 
.5283 
.5190 
.0001 
.5535 
.0001 
.0558 
.6808 
DFFT -.1532 
,2496 
.2528 
.0525 
.1151 
,6060 
.7079 
.0001 
.8625 
.0001 
.0676 
.6199 
.1241 
,6441 
.8835 
.0001 
FCD .1480 
.2669 
.1225 
.6377 
.0043 
.9730 
.3601 
.0056 
.4270 
.0012 
.0728 
.5938 
.0038 
.9758 
.4176 
.0015 
FCSA 1383 
3009 
.1935 
,1418 
.0734 
.5908 
.4365 
.0009 
.5430 
.0001 
,1161 
.6107 
.0348 
.7912 
.5312 
.0001 
FCV ,1154 
,6076 
.2451 
.0604 
,1347 
.3145 
.4915 
.0002 
.6267 
.0001 
,1413 
.2900 
.0514 
.7034 
.6138 
.0001 
FCN .1664 
.2093 
.4810 
.0003 
.3062 
.0184 
.4330 
.0010 
.6745 
.0001 
.3306 
.0109 
.2851 
.0283 
.6608 
.0001 
SFFA .0719 
.5980 
,1536 
.2481 
.1851 
,1608 
.3158 
.0150 
.3787 
.0037 
.0432 
.7461 
.0195 
.8790 
.3771 
.0038 
FFAC ,2498 .4456 .2168 -.3757 -.6351 .5536 -.4347 -.6053 
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LD DFFT FCD FCSA FCV FCN SFFA FFAC 
1.0000 .0418 
.0000 .7537 
.0418 
.7537 
-.1356 
.3110 
-.1192 
.6238 
-.0960 
.5195 
-.0671 
.6225 
.1912 
.1467 
.2951 
.0231 
1.0000 
.0000 
.3615 
.0055 
.4511 
.0006 
.5158 
.0001 
.5284 
.0001 
.3303 
.0110 
-.4744 
.0004 
-.1356 
.3110 
.3615 
.0055 
1.0000 
.0000 
.9810 
.0001 
.9350 
.0001 
-.3109 
.0166 
.2549 
.0506 
-.0521 
.6997 
-.1192 
.6238 
.4511 
.0006 
.9810 
.0001 
1.0000 
.0000 
.9852 
.0001 
-.1958 
.1370 
.3181 
.0143 
-.1415 
.2894 
—.0960 
.5195 
.5158 
.0001 
.9350 
.0001 
.9852 
.0001 
1.0000 
.0000 
-.0976 
.5274 
.3530 
.0066 
-.2053 
.1182 
-.0671 
.6225 
.5285 
.0001 
-.3109 
.0166 
-.1958 
.1370 
-.0976 
.5274 
1.0000 
.0000 
.1770 
.1806 
-.6639 
.1912 
.1467 
.3303 
.0110 
.2549 
.0506 
.3181 
.0143 
.3530 
.0066 
.1770 
.1806 
1.0000 
.0000 
-.2588 
.2951 
.0231 
-.4744 
.0004 
-.0521 
.6997 
-.1415 
.2894 
-.2053 
.1182 
-.6639 
.0001 
-.2588 
.0470 
1.0000 
.0000 
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release increased with increases in the final TSR and seminal 
vesicle weight. 
The rate of FFA release was not significantly related to cell 
diameter, cell surface axea, or cell volume. The important factor 
in cellulaxity effects on lipolysis was the number of cells present 
in the adipose tissue. The TP treated amimals had the smallest 
number of fat cells and the highest rate of FFA release. The hor­
mone may have been able to reach and stimulate more fat cells in 
the TP treated animals because of more DFFT present on a percentage 
basis (dfft ~ fat depot wt. • 100). This DFFT is composed of 
emptied fat cells, connective tissue, and capillaories. If more 
capillaries are present to deliver the hormone to the cells, more 
cells would be reached by the hormone aoid stimulated to release 
FFA, Thus, more FFA could be released by adipose tissue composed 
of a smaller number of cells and many capillaries than by adipose 
tissue ccmpcscd of a large number cf cclls and fsv.'sr capillaries. 
Another possible explanation for the increased rate of lipolysis 
is that TP affects the adenosine 3', 5*-monophosphate (c-AMP) 
system. An increase in FFA release could be caused by the activa­
tion of adenyl cyclase; the inhibition of phosphodiesterase; or 
increased synthesis of adenosine triphosphate (ATP), adenyl cyclase, 
protein kinase, or the lipase. Finally, lipolysis may have been 
increased in the TP treated animals by a combination of greater 
blood supply to the fat cells and activation of some portion of the 
c-AMP system. 
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In this study, the possibility that the secretions of the 
adrenal glaind stimulated FFA release can be ruled out. Hie FFA re­
lease in the animals with hypertrophied adrenal glands (castrate and 
EB treated) was significaxitly less than in the TP treated animals 
with glands weights similar to control animals. The possibility 
still exists that TP may have stimulated another hormone system, 
such as growth hormone, to cause the increase in FFA release. This 
will have to be resolved by another study. However, regardless of 
whether the action was direct or indirect, TP did stimulate FFA re­
lease from the retroperitoneal fat depot. 
Serum FFA levels were significantly correlated to final body 
weight, retroperitoneal fat depot weight, total lipids, DFFT, fat 
cell surface airea, and fat cell volume. The correlation coefficients 
for these variables are 0.3158 at p < 0.0150, 0.3787 at p < 0.0037, 
0.3771 at p < 0.0038, 0.3303 at p < 0.0110, 0.3181 at p < 0.0143, and 
0.3530 at p < 0.0066. In sinamary, as serusi FFA levels increased, 
increases were also observed in final body weight, retroperitoneal 
fat depot weight, total lipids, DFFT, fat cell surface area, and 
fat cell volume. 
The observed decreases in serum FFA levels with TP and EB 
treatment does not agree with previous studies which reported in­
creased serum levels of FFA with hormone treatment (Laron and 
Kowadlo, 1963; Laron and Kowadlo-Silbergeld, 1964; Laoron and 
Kowadlo-Silbergeld, 1965a; Laron and Kowaldo-Silbergeld, 1965b). 
Higher serum FFA levels were not found in castrate animais when 
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compared with control animals as reported by Nikul*cheva (1969). 
However, aill of these studies used animals which had been fasted 
24 hours or longer. The results of these studies may have been 
influenced by fasting-induced FFA release. 
The data showing decreased serum FFA concentrations in EB 
treated animals is supported by reports by Hess (1964) and Larsson-
Cohn ^  aZ. (1970). The results of these two studies varied with 
the type of hormone and the dosage given. Plasma FFA levels were 
reduced more with higher doses of estrogens. The dosage of EB used 
in the present study (1.0 jag per day) is probably a pharmacological 
dose for maJLe animaJLs. This could account for the lower serum 
FFA concentrations in EB treated animals. 
Even though the TP treated animals exhibited the highest rate 
of FFA release from the retroperitoneal fat depot, they had lower 
serum FFA levels than the control and castrate animals. This sug­
gests more rapid utilization of serum FFA by xhe IP treated group. 
The rate of release of FFA from the retroperitoneal fat depot of 
EB treated amimals was near that observed in control animals, while 
the serum FFA levels were the lowest recorded. These facts also 
suggest increased serum FFA utilization. Both TP smd EB are known 
to have anabolic properties. It seems likely that the muscles and 
livers of the TP and EB treated animals are using the serum FFA 
more rapidly thsm muscles and livers of control auid castrate 
smimaJs. The data gathered in this study does not prove this to 
be true. However, the following observations in the hormone treated 
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animals certainly do suggest this may occur: decreased serum FFA 
levels, small body weight gains, small retroperitoneal fat depots, 
aund small amounts of total lipids in the retroperitoneal fat depot. 
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SUMMARY 
This study was designed to investigate the effects of testos­
terone propionate (TP) and estradiol benzoate (EB) on the thyroid 
hormone secretion rates (TSR) and on retroperitoneal adipose tissue 
cellulaxity and lipid mobilization in rats. Young, castrated, male 
rats were injected with either 0.6 mg TP per day, 1,0 p,g EB per day 
or 0.1 ml of the vehicle per day for ten weeks. The TSR was measured 
before surgical amd hormonal intervention and after seven weeks of 
hormonal treatment. Retroperitoneal adipose tissue cell size and 
number, the rate of free fatty acid (FFA) release from the retro­
peritoneal fat depot, aoid serum FFA levels were determined at the 
end of the experimental period. 
The results of this study were; 
1. The TSR was significantly increased by TP treatment, 
but was unchanged by castration and EB treatment. 
2. Body weight gains were significantly lowered in 
castrate, TP and EB treated animals. Tissue weights 
were also affected by treatment. Retroperitoneal fat 
depot weights were significantly reduced in TP and EB 
treated animals, while castration had no effect. 
Seminal vesicle weights were significantly reduced by 
castration ajid EB treatment and significajitly increased 
by TP treatment. Adrenal glsmd weights were signifi-
caoitly increased by castration and EB treatments, while 
TP treatment had no effect. 
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Retroperitoneal fat cell diameters were not signifi­
cantly affected by castration or hormone treatments. 
While fat cell surface area and volume were increased 
by castration and hormone treatments, the data were 
not significantly different from values in control 
animals. Retroperitoneal fat cell numbers were signifi­
cantly reduced by TP treatment, while a small nonsignifi-
camt decrease was observed with EB treatment. 
Total lipids, lipid densities, and dry fat-free tissue 
weights (DFFT) from the retroperitoneal fat depot were 
recorded. Total lipids emd DFFT were reduced by hormone 
treatment sind unchanged by castration. Lipid densities 
were decreased by castration ajid EB treatment and were 
unchanged by TP treatment. 
The rate of FFA release from the retroperitoneal fat 
depot was significantly increased by TP treatment and 
unaffected by castration and EB treatment. Serum FFA 
levels were significajitly reduced by hormone treatments 
and unaffected by castration. 
The final TSR was positively correlated with FFA release 
from the fat depot and negatively correlated with retro­
peritoneal fat depot weights, seminal vesicle weights, 
adrenal glajmd weights, total lipids, and fat cell numbers. 
All expressions of fat cell size (diameter, surface area, 
and volume) were positively correlated with the final body 
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weights, retroperitoneaJL fat depot weights, total 
lipids, and DFFT. Retroperitoneal fat cell number was 
negatively correlated with the final TSR and positively 
correlated with the final body weights, retroperitoneal 
fat depot weights, total lipids and DFFT. 
8. Release of FFA from the retroperitoneal fat depot was 
positively correlated with the final TSR and negatively 
correlated with the final body weights, retroperitoneal 
fat depot weights, seminal vesicle weights, adrenal gland 
weights, total lipids, DFFT, and fat cell numbers. Serum 
FFA levels were positively correlated with final body 
weights, retroperitoneal fat depot weights, total lipids, 
DFFT, fat cell surface area and fat cell volume. 
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APPENDIX A: ORCHIDECIOMY 
The animals were anesthetized with ether and placed on their 
backs. The scrotal area was shaved and cleansed with 70% ethyl 
alcohol. A mid-line incision was made through the skin of the 
scrotum. If the testes had been retracted into the abdominal 
cavity, gentle pressure above the pelvic bones lowered them back 
into the scrotum. The testes were freed from the surrounding 
tissues by blunt dissection. 
The tunica vaginalis was lifted from the surface of the testis 
with foreceps, allowing a small slit to be made through the tunica 
with scissors. Slight pressure on the proximal portion of the 
testis forced it through the opening in the tunica. The epididymis 
and surrounding epididymal fat pad were cairefully dissected away 
from the body of the testis until the testicular artery was fully 
exposed. The artery was clamped off and ligated on each side of 
the clamp. After the clamp was removed, the artery was cut between 
the two ties freeing the testis. The epididymis and epididymal fat 
pad were gently placed back in the tunica which was re-positioned 
in the scrotum. The other testis was removed by the same procedure. 
The incision through the scrotal skin was pulled together and 
closed with wound clips. The animal was returned to its cage and 
allowed to recover for two weeks before treatments were initiated. 
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APPENDIX B: PREPARATION OF HORMONE SOLUTIONS 
Testosterone Propionate 
Testosterone propionate (CaJ-biochem, La Jolla, California), 
600 mg/lOO ml, was dissolved in corn oil The solution was stirred 
overnight on a magnetic stirrer to insure complete dissolving and 
mixing of the hormone in the corn oil. This solution gave a dose 
concentration of 0.6 mg/O.l ml. 
Estradiol Benzoate 
A stock solution of 1.0 mg/ml of estradiol benzoate (Nutri­
tional Biochemicals Corporation, Cleveland, Ohio) dissolved in corn 
oil was used. This solution was completely mixed by stirring over­
night on a magnetic stirrer. An aliquot of the stock solution was 
diluted with corn oil to a final dose concentration of 1.0 [ig/O.l 
ml. After dilution, this solution was also stirred overnight be­
fore use. 
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APPENDIX C: THYROID SECRETION RATE DETERMINATION 
The iodine-131-thyroxine substitution method of determining 
the TSR is based upon the principle that exogenous thyroxine will 
prevent the release of thyroid hormones from the thyroid gland by 
the negative feedback mechanism on the hypothalamus and pituitary. 
131 
The animal is given I, which is incorporated by the thyroid 
glcind into the thyroid hormones. The daily TSR cam be estimated 
by determining the amount of exogenous thyroxine that is needed 
131 
to block the release of the I labeled thyroid hormones from the 
gland. 
Materials 
Iodine-131, 1.0 mci in 0.1 ml of O.IM NaOH (New England Nuclear, 
Boston, Massachusetts) was diluted to 5.0 uci/O.l ml with distilled 
water. 
A stock solution of L-thyroxine, sodium salt, (Nutritional Bio-
chemicals Corporation, Cleveland, Ohio) was prepaored to give a 
concentration of 100 jig/ml. 
1. Twenty milligrams of L-thyroxine was placed in a 200 ml 
volumetric flask = A IN NaOH solution was used to rinse 
all equipment. 
2. Approximately 100 ml of distilled, deionized water was 
used to dissolve the thyroxine. 
3. A IN HCl solution was added slowly, with mixing eifter 
each addition, until the pH was lowered to the point 
89 
where the thyroxine precipitated out as a white 
flocculent material (approx. pH 6.0). Care was taken 
not to over shoot this end point since this would cause 
overdilution when the injection solutions are made. 
4. The solution was diluted to 200 ml with distilled, 
de ionized water. This stock solution cam be stored 
under refrigeration for up to one yeair. 
Dilution of the L-thyroxine stock solution for the injection 
solutions was accomplished as follows; 
1. After thorough shaking of the stock solution, an aliquot 
of calculated volume was removed. 
2. This aliquot was diluted with distilled, deionized water 
to give the desired concentration of thyroxine/0.1 ml. 
3. A IN NaOH solution was added dropwise, with mixing after 
each addition, until the precipitate disappeared. The 
final pK was approximately 7.0. This solution was ready 
for injection and was stable under refrigeration for 48 
hours. 
The radiation detection equipment used included a Nuclear 
Chicago DS-5, two inch NaT scintillation crystal coupled with a 
Nuclear Chicago 1620A count rate meter. 
90 
Procedures 
1. Each animal was injected subcutaneously with 5 |ici/0-l 
131 
ml of I, while lightly anesthetized with ether. 
2. Forty-eight hours later, external thyroid counts were 
made by placing the thyroid area of the ether anesthe­
tized animal over the well of the solid scintillation 
detector. The counts per minute (cpm) were recorded. 
Counts were made every 48 hours at approximately the 
saone time of day. 
3. Immediately after recording the cpm, thyroxine injections 
were started. The subcutaineous injections were given 
once daily starting at a concentration of 0.25 p.g/O.1 ml/ 
100 g body weight. Every other day, the concentration 
was increased by increments of 0.25 p,g/0.1 ml/lOO g body 
weight. Injections were given at approximately the same 
time each day. 
4. The cpm were corrected for background and decay and the 
percent of the previous cpm was calculated. 
The best estimate of the TSR was considered to be the dosage 
of thyroxins given for the two days prior to the time when the cpm 
was 95-100% of the previous cpm. Although several hormones are 
secreted by the thyroid glemd, the TSR is expressed as |ag L-thyrox­
ine/100 g body weight/day. Since determinations aire standardized, 
more valid compearisons can be made. 
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This technique requires the use of a goitrogen to prevent 
recycling of iodine in many species. No goitrogen is required for 
the rat since the release of iodine from the thyroid gland is suf­
ficiently steep (Anderson, 1969). 
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APPENDIX D: INCUBATION MEDIA 
The following aqueous stock solutions were prepsured prior 
to making up the Krebs-Ringer bicarbonate medium. 
1. 0.90% NaCl 
2. 1.15% KCl 
3. 1.22% CaCl^—Five milliliters of this solution was equiva­
lent to 11.0 ml of O.IN AgNO^. 
4. 2.1155 KHgPO^  
5. 3.82% MgSO^.TH^O 
The above solutions were made up at five times the required con­
centration since the more concentrated solutions were stable for 
months under refrigeration (Umbreit et , 1949). 
6. 1.30% NaHŒ)^ 
This solution (6) was gassed with 00^ until a pH of 8.2-10.0 was 
reached, usually about 20-30 minutes. 
The following amounts were used to prepare Krebs-Ringer 
bicairbonate medium. 
1. 100.0 ml (parts) of NaCl solution 
2. 4.0 ml (parts) of KCl solution 
3. 3.0 ml (parts) of CaCl^ solution 
4. 1.0 ml (parts) of KH^PO^ solution 
5. 1.0 ml (parts) of MgSO^'TH^O solution 
These solutions were mixed together thoroughly and the final 
volume reduced to 100 ml. To correct for the more concentrated 
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stock solutions, the 100 ml of Krebs-Ringer solution was diluted 
to 500 ml with distilled water. 
6. 16.0 ml of the NaHCO^ solution was diluted to 100 ml 
with the Krebs-Ringer solution (above). 
This Krebs-Ringer bicarbonate medium is stable in a glass-stoppered 
vessel for one week under refrigeration. 
For the FFA release incubation, 40 ml/ml of aJ-bumin Bovine 
Fraction V Powder (unesterified fatty acid poor) (Nutritional 
Biochemicals Corporation, Cleveland, Ohio) was added to the volume 
of Krebs-Ringer bicarbonate medium required. 
For the incubation to liberate fat cells, 40 mg/ml of albumin, 
10 mg/ml of B Grade Collagenase R (CaJ.biochem, La Jolla, California), 
and 3.0 limoles/ml of glucose were added to the volume of Krebs-
Ringer bicaorbonate medium required. 
The pH of both incubation media was adjusted to 7.4, if 
necessary. The media were gassed for 10 minutes with 95% -
5% COg and kept on ice until use. 
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APPENDIX E; FREE FATTY ACID EXTRACTION 
Materials 
All solvents for the extraction mixture were re-distilled and 
then combined in the following proportions: 
1. Isopropyl alcohol—40 parts 
2. Heptane—10 parts 
3. IN H^SO^—1 part 
Procedures 
Extraction of FFA released from adipose tissue 
1. One milliliter of incubation medium was placed in a glass-
stoppered test tube. 
2. Five milliliters of the extraction mixture was added. 
3. The tube containing the above solutions was shaken 
thoroughly and allowed to stand at room temx>eratv.re ap­
proximately five minutes. 
4. Two milliliters of distilled water was added. 
5. Three milliliters of heptane was added. 
6. The tube was again shaken thoroughly and allowed to stand 
at room temperature. Within five minutes, the system 
separated into two phases. 
7. The upper orgsunic phase containing the FFA was removed 
said stored in tightly sealed one dram vials at -20°C 
until use. 
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Extraction of serum FFA 
1. Ten microliters of serum was placed in a micro poly­
ethylene snap-cap tube (Beckman micro centrifuge tube). 
2. Fifty microliters of extraction mixture was added. 
3. These solutions were mixed well on a vortex mixer for 
at least 15 seconds. 
4. One hundred microliters of heptane was added. 
5. One hundred microliters of distilled water was added. 
6. These solutions were mixed on a vortex mixer for at 
least 15 seconds. 
7. The micro polyethylene snap-cap tubes were placed in 
larger plastic tubes and centrifuged for five minutes 
at 400 g to aid in the sepaoration of phases. 
8. Eighty microliters of the upper organic phase, con­
taining the FFA, was removed and placed in another micro 
polyethylene snap-cap tube containing 5.0 mg of silicic 
acid. 
9. Eighty microliters of chloroform was added quickly. 
10. These solutions were mixed for at least 15 seconds on a 
vortex mixer emd then centrifuged at 400 g for five 
minutes. 
11. Fifty microliters of the upper silicic acid treated 
organic phase was used in the FFA assay. 
The preceding four steps removed the serum phospholipids, 
since they interfere with the FFA assay. 
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APPENDIX F: 
FREE FATTY ACID ASSAY USING NICKEL-63 
Materials 
Stsmdard stock solutions (200 nmoles/50 |il) were made by 
dissolving the crystallized fatty acids in heptane. Aliquots of 
these stock solutions were diluted to give standard solution con­
centrations of 1, 2, 4, 8, 12, 16, and 20 nmoles FFA/50 |j,1. The 
fatty acids used were capric acid (Schwaxz/Mann, Orangeburg, N.Y.), 
caproic acid (Schwaxz/Mann, Orangeburg, N.Y.), myristic acid 
(Schwarz/Mctnn, Orangeburg, N.Y.), palmitic acid (Nutritional Bio-
chemicals Corporation, Cleveland, Ohio), zind stearic acid (Schwarz/ 
MaJin, Orangeburg, N.Y.). The FFA staindaards were assayed by the same 
procedure as the experimental FFA samples. 
The following solutions were prepsored for use in the FFA 
assay: 
1. Glacial acetic acid, 0.8 ml, and 0.2 mmoles of Ni(NO^) 
6HgO were dissolved in a saturated aqueous solution of 
Na^SO^ and taken to 100 ml with the same solution. This 
concentration of Ni(NOg)g was recommended by Ho (1970) 
for use with serum or plasma since it increases the 
specific activity of the ^^Ni present in the working 
solution. In the present study, this concentration was 
used to assay the serum eind incubation medium FFA because 
of the low levels of FFA encountered in the incubation 
medium. 
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Two millleurles of in 0.1 ml of O.IM HNO^ was ob­
tained from New England Nucleao: (Boston, Massachusetts). 
After the HNO^ was evaporated off, the 2.0 mci of ^ ^Ni 
nitrate were diluted with the above solution (1) to a 
concentration of 2.0 uci/lO |il of Ni(NO^)g solution. 
A saturated aqueous solution of K^SO^ was prepared. 
The ^^Ni working solution was prepared fresh daily 
before use. 
a. ^^Ni stock solution (2)—10 volumes 
b. Saturated aqueous K^SO^ solution (3)—8.5 volumes 
c. Triethanolamine—1.5 volumes 
These solutions were mixed thoroughly. Ten microliters 
of this working solution contained 100 nmoles of Ni(NOg)^ 
and had a specific activity of 1.0 x 10^ cpm (gas-flow 
counter, 28% counting efficiency for ^^Ni). 
A chloroform : heptaoie solution (4:1, viv) was prepcuced 
for use in the incubation medium FFA assay. The chloro­
form : heptane solution used with the serum FFA assay was 
mixed in the proportions of 55:45 (v:v). 
Bray's liquid scintillation fluid was used in the liquid 
scintillation counting system, 15 ml per vial. 
1. 4.0 g PPG 
2. 0.05 g POPOP 
3. 120.0 g napthalene 
4. 20.0 ml ethylene glycol 
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5. Dioxaine was added to the above to make a 
total volume of one liter. 
A Beckmsm LS-250 liquid scintillation counter was used to 
measure the levels of ^ ^Ni. 
Procedures 
Incubation medium FFA Assay 
1. Fifty microliters of the extracted FFA in heptane was 
added to a micro polyethylene snap-cap tube. 
2. One hundred microliters of chloroform : heptane solution 
(1:4, v;v) was added. 
3. Ten microliters of the ^^Ni working solution was added 
and the tube tightly sealed with the attached snap-cap. 
4. This mixture was stirred thoroughly on a vortex mixer for 
30 seconds. 
5. The micro polyethylene tubes were placed in larger plastic 
tubes (a safety precaution in case of ^^Ni leakage) and 
centrifuged for five minutes at 400 g. This separated 
the system into a lower aqueous phase and an upper organic 
phase containing the ^^Ni-FFA complex. 
6. Fifty microliters of the upper orgeinic phase was removed 
ajid placed in liquid scintillation counting vials. 
7. The solvents were allowed to evaporate off before the 
Bray's liquid scintillation fluid was added to the viaJLs. 
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FFA assay 
1. Fifty microliters of the silicic acid treated FFA extrac­
tion was placed in a micro polyethylene snap-cap tube. 
2. One hundred microliters of chloroform : heptane solution 
(55:45, v:v) was added. 
3. Ten microliters of the ^^Ni working solution was added 
and the tube tightly sealed with the attached snap-cap. 
4. This mixture was stirred thoroughly on a vortex mixer 
for 30 seconds. 
5. The micro polyethylene tubes were placed in larger plastic 
tubes and centrifuged at 400 g for five minutes. 
6. Fifty microliters of the upper organic layer containing the 
^^Ni-FFA complex were removed and placed in liquid scin­
tillation vials. 
7. After evaporation of the solvents. Bray's liquid scin-
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APPENDIX G; 
FIXATION AND SEPARATION OF ISOLATED FAT CELLS 
All glasswaure used in prepairing the solutions described 
below was acid-washed, thoroughly rinsed in distilled water, dried, 
rinsed with acetone, and dried before use. The water used in the 
prepaoration of the solutions was double distilled. 
Materials 
Milloniq's phosphate buffer 
1. Seventeen milliliters of a 2.52% NaOH solution was added 
to 83.0 ml of a 2,26% NaH^PO^ solution. 
2. The resulting solution was mixed w-*jlx aoid 10 ml was 
decemted off. 
3. Ten milliliters of a 10% sucrose solution was added. 
This brought the osmolality of the solution to approxi­
mately 300 milliosmoles, which is isotonic with mammalian 
plasma. 
4. The pH was adjusted to 7.4. 
Osmium tetraoxide solution 
The osmium tetraoxide (J. A. Samuels and Co., Inc., New York, 
N.Y.) was obtained in pre-scored glass viaJ-s, each containing one 
gram of crystalline osmium tetraoxide. Note: euLl work involving 
osmium was done in a hood. 
A one gram vial was carefully wsarmed in warm water to melt the 
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crystals of osmium. When all crystals were melted, the vial was 
removed from the warm water said aULlowed to cool. The vial was 
rotated so that the osmium recrystaZlized in a thin layer on aJLl 
inner surfaces of the vial. This aided in dissolving the osmium 
when it was added to the buffer. The vial was then rinsed in ace­
tone and air dried. It was important from this point on, not to 
touch the vial with fingers as this would have left traces of oil 
which would have caused reduction of the osmium solution. 
The vial was gently slipped into a glass-stoppered bottle 
containing 99.0 ml of Millonig's phosphate buffer. After the 
bottle was stoppered amd sesuled with paxafilm, it was shaorply 
rapped against the palm of the hand. This action broke the vial 
containing the osmium and allowed the buffer to enter the vial. 
After stamding overnight at room temperature to allow the osmium 
to completely dissolve, five ml aliquots were removed, sealed in 
plastic tubes, and stored at -20*^0 until use. 
Procedures 
A five ml aliquot of the 1% osmium tetraoxide-phosphate 
buffer solution was added to each plastic tube of washed fat cells. 
Fixation at room temperature was allowed to continue for at least 
three days. 
After fixation, the contents of the plastic tube were thorough­
ly washed through a 250 |i nylon screen (Tobler, Ernst and Traber, 
Inc., Elmsford, N.Y.) with distilled water. This sepaorates the 
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fat cells from any remaining stromaJL-vascular tissue, leaving the 
stromal-vascular tissue on the filter and allowing the fat cells to 
go through the filter with the filtrate. The filtrate was then 
washed onto a 25 ji nylon screen with distilled water. The fat cells 
were trapped on the nylon screen. After thorough rinsing with dis­
tilled water, the fat cells were rinsed with physiological saline 
into plastic vials. The fat cells were stored in the saline-filled 
viaJLs until measurement of the cells could be completed. 
